Using non-small-cell lung carcinoma cells in which SFRP1 was methylated, they showed that when SFRP1 was cotransfected with mutant β-catenin, SFRP1 could attenuate TCF/LEF activity induced by exogenous β-catenin. Here, HNF4A is linked to non-small cell lung carcinoma.